XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
https://www.clinicaltrialsarena.com/uncategorized/newsjanssen-signs-exclusive-development-commercialisation-agreement-for-daratumumab/20%Daily2012-08-30 17:30
https://www.clinicaltrialsarena.com/uncategorized/newssoligenix-adjuvanted-rivax-induces-immune-responses-in-human-volunteers/20%Daily2012-08-30 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsspinifex-phase-ii-ema401-trial-meets-primary-endpoint/20%Daily2022-03-22 07:16
https://www.clinicaltrialsarena.com/uncategorized/newscollegium-starts-enrolment-in-phase-iii-pain-study-of-oxycodone-deterx/20%Daily2012-08-29 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsnanoviricides-oral-anti-influenza-candidates-demonstrate-lung-viral-load-decrease/20%Daily2012-08-28 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsaeterna-zentaris-begins-phase-iia-trial-in-cancer-cachexia-patients/20%Daily2012-08-28 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsgenentech-phase-iii-emilia-study-meets-co-primary-efficacy-endpoints/20%Daily2012-08-27 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsmorphotek-commences-phase-ii-study-of-morab-004/20%Daily2012-08-27 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsnovira-to-advance-development-of-capsid-targeting-antivirals/20%Daily2012-08-26 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsseattle-genetics-commences-phase-ib-renal-cell-carcinoma-trial/20%Daily2012-08-26 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsisaec-uc-san-diego-partner-for-research-into-diri-genetics/20%Daily2012-08-23 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsgsk-janssen-begin-phase-iii-ra-sirukumab-programme/20%Daily2012-08-23 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsphasebio-begins-phase-2b-type-2-diabetes-trial-of-glymera/20%Daily2012-08-22 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsbiota-phase-iii-inavir-study-meets-primary-endpoint/20%Daily2012-08-22 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsnanoviricides-reports-survival-improvements-of-oral-flucide-drug-candidates/20%Daily2012-08-21 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsallergan-molecular-partners-to-develop-darpin-products-for-eye-diseases/20%Daily2012-08-21 17:30
https://www.clinicaltrialsarena.com/uncategorized/newscdd-sri-receive-niaid-grant-to-develop-tuberculosis-drug-discovery-computational-tools/20%Daily2012-08-20 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsocular-therapeutix-enters-pilot-phase-ii-travoprost-punctum-plug-trial/20%Daily2021-12-02 05:56
https://www.clinicaltrialsarena.com/uncategorized/newslexicon-reports-positive-preliminary-results-from-phase-i-studies-of-lx2931-lx7101/20%Daily2012-08-19 17:30
https://www.clinicaltrialsarena.com/uncategorized/newstg-therapeutics-rhizen-partner-to-develop-cancer-drug/20%Daily2012-08-19 17:30
https://www.clinicaltrialsarena.com/uncategorized/newssenesco-sns01-t-meets-criteria-for-stable-disease-in-first-cohort-of-phase-1b2a-trial/20%Daily2012-08-16 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsoncolytics-completes-enrolment-in-uk-phase-i-cancer-trial/20%Daily2012-08-16 17:30
https://www.clinicaltrialsarena.com/uncategorized/newssoricimed-commences-patient-treatment-in-phase-i-trial-of-sor-c13/20%Daily2012-08-15 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsgenocea-begins-phase-12a-hsv-2-investigational-vaccine-study/20%Daily2012-08-15 17:30
https://www.clinicaltrialsarena.com/marketdata/featurenew-markets-api-manufacturing-india-china/20%Daily2012-08-15 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsmeritage-pharma-begins-phase-2-trial-of-obs/20%Daily2012-08-14 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsuk-mhra-unveils-new-simplified-medicines-regulations/20%Daily2012-08-14 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsgenentech-reports-phase-iii-avaglio-study-results/20%Daily2012-08-13 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsacorda-post-marketing-commitment-study-fails-to-confirm-ampyra-5mg-efficacy/20%Daily2012-08-13 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsgalenea-chdi-foundation-expand-huntingtons-disease-collaboration/20%Daily2012-08-12 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsfda-clears-genentech-lucentis-injection-for-dme-treatment/20%Daily2012-08-12 17:30
https://www.clinicaltrialsarena.com/uncategorized/newssynthetic-biologics-intrexon-to-address-unmet-needs-of-infectious-diseases/20%Daily2012-08-09 17:30
https://www.clinicaltrialsarena.com/uncategorized/newstigenix-completes-enrolment-in-phase-iia-rheumatoid-arthritis-study/20%Daily2012-08-09 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsaffinium-completes-recruitment-in-phase-2-absssi-trial-of-afn-1252/20%Daily2012-08-08 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsamgen-terminates-ganitumab-phase-3-gamma-trial/20%Daily2012-08-08 17:30
https://www.clinicaltrialsarena.com/uncategorized/newstwi-reports-positive-results-from-phase-iib-study-of-ac-201/20%Daily2012-08-07 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsnektar-commences-phase-2-study-of-etirinotecan-pegol/20%Daily2012-08-07 17:30
https://www.clinicaltrialsarena.com/uncategorized/newspfizer-oab-drug-meets-primary-endpoint-in-phase-4-study/20%Daily2012-08-06 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsoxigene-phase-2-ovarian-cancer-study-meets-safety-criteria/20%Daily2012-08-06 17:30
https://www.clinicaltrialsarena.com/uncategorized/newspfizer-phase-3-bapineuzumab-study-fails-to-meet-co-primary-endpoints/20%Daily2012-08-06 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsbiodelivery-endo-commence-phase-3-programme-for-bema-buprenorphine/20%Daily2012-08-05 17:30
https://www.clinicaltrialsarena.com/marketdata/featuretop-5-expired-blockbuster-drugs/20%Daily2012-08-05 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsinsite-initiates-phase-3-clinical-trial-of-bromsite/20%Daily2012-08-02 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsnymox-bph-drug-shows-positive-treatment-outcomes-compared-to-placebo/20%Daily2012-08-02 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsarray-biopharma-arry-797-meets-primary-endpoint-in-phase-2-trial/20%Daily2012-08-01 17:30
https://www.clinicaltrialsarena.com/uncategorized/newsacetylon-begins-combination-study-of-rocilinostat-with-revlimid-dexamethasone/20%Daily2012-08-01 17:30